Belite Bio Reports Unaudited First Quarter 2026 Financial Results and Provides a Corporate Update

Go back to Belite Bio Reports Unaudited First Quarter 2026 Financial Results and Provides a Corporate Update
(NASDAQ: BLTE) Delayed: 147.07 +0.95 (0.65%)
Previous Close $146.12    52 Week High
Open $147.63    52 Week Low
Day High $150.00    P/E N/A 
Day Low $144.79    EPS
Volume 172,429